A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

2004 ◽  
Vol 2 (3) ◽  
pp. 127 ◽  
Author(s):  
M Untch ◽  
S Kahlert ◽  
L Petruzelka ◽  
M Martin ◽  
V Guillem-Porta ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
Her2 Positive ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

BMC Cancer ◽  
2005 ◽  
Vol 5 (1) ◽  
Author(s):  
Djelila Allouache ◽  
Sulochana R Gawande ◽  
Michele Tubiana-Hulin ◽  
Nicole Tubiana-Mathieu ◽  
Sophie Piperno-Neumann ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Locally Recurrent

scholarly journals Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

2006 ◽  
Vol 94 (11) ◽  
pp. 1604-1609 ◽  
Author(s):  
F Ciardiello ◽  
T Troiani ◽  
F Caputo ◽  
M De Laurentiis ◽  
G Tortora ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document